Voyageur Pharmaceuticals Ltd
XTSX:VM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Voyageur Pharmaceuticals Ltd
Total Current Liabilities
Voyageur Pharmaceuticals Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Voyageur Pharmaceuticals Ltd
XTSX:VM
|
Total Current Liabilities
CA$2.2m
|
CAGR 3-Years
84%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Total Current Liabilities
$4.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Total Current Liabilities
$41.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Total Current Liabilities
CA$165.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
38%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Total Current Liabilities
CA$67.4m
|
CAGR 3-Years
188%
|
CAGR 5-Years
93%
|
CAGR 10-Years
37%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Total Current Liabilities
$20.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
3%
|
|
Voyageur Pharmaceuticals Ltd
Glance View
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The firm is focused on the development of barite and iodine Active Pharmaceutical Ingredients (API) and imaging contrast agents for the medical radiology marketplace. The company owns a 100% interest in three barium sulfate (barite) projects. The firm operates through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc. The company is focused on developing its barium sulfate project, Frances Creek, in BC, Canada for pharmaceutical barium contrast applications, such as x-radiation, computed tomography scans and magnetic resonance imaging applications. The company also owns mineral brine claims in Utah United States, including Frances Creek, Jubilee Mountain and Pedley Mountain.
See Also
What is Voyageur Pharmaceuticals Ltd's Total Current Liabilities?
Total Current Liabilities
2.2m
CAD
Based on the financial report for Aug 31, 2025, Voyageur Pharmaceuticals Ltd's Total Current Liabilities amounts to 2.2m CAD.
What is Voyageur Pharmaceuticals Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
23%
Over the last year, the Total Current Liabilities growth was 63%. The average annual Total Current Liabilities growth rates for Voyageur Pharmaceuticals Ltd have been 84% over the past three years , 23% over the past five years .
